Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 22,901–22,925 of 27,380 studies, newest first · page 917 of 1096.

November 2006 14

  1. 2006-11-01

    Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

    ✓ Peer-reviewed Treatments Movement disorders : official journal of the Movement Disorder Society

    Key finding: This was a 24-week double-blind placebo-controlled study. +3 more findings

  2. 2006-11-01

    Progression of mild cognitive impairment to dementia: a challenge to current thinking

    ✓ Peer-reviewed Mild cognitive impairment The British journal of psychiatry : the journal of mental science

    Key finding: Further long-term studies are needed to examine the time-dependent evolution from mild cognitive impairment to dementia and to establish age-specific conversion rates during lifetime.

  3. 2006-11-01

    Vitamin B12, folic acid, and the nervous system

    ✓ Peer-reviewed Lewy body dementia The Lancet. Neurology

    Key finding: There are many reasons for reviewing the neurology of vitamin-B12 and folic-acid deficiencies together, including the intimate relation between the metabolism of the two vitamins, their morphologically indistinguishable megaloblastic anaemias, and their overlapping neuropsychiatric syndromes and neuropathology, including their related inborn errors of metabolism. +2 more findings

  4. 2006-11-01

    Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review

    ✓ Peer-reviewed Disparities Archives of internal medicine

    Key finding: Three randomized controlled trials (RCTs) and 6 single-case designs (SCDs; N of 1 trials) met inclusion criteria. +3 more findings

  5. 2006-11-01

    Dementia care: mental health effects, intervention strategies, and clinical implications

    ✓ Peer-reviewed Caregiving The Lancet. Neurology

    Key finding: Caring for elderly people with dementia is associated with well-documented increases in burden, distress, and decrements in mental health and wellbeing. +1 more finding

  6. 2006-11-01

    The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial

    ✓ Peer-reviewed Caregiving Annals of internal medicine

    Key finding: A dementia guideline-based disease management program led to substantial improvements in quality of care for patients with dementia.

  7. 2006-11-01

    Proteome-based plasma biomarkers for Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: These findings suggest that blood may be a rich source for biomarkers of Alzheimer's disease and that CFH, together with other proteins such as alpha-2M may be a specific markers of this illness.

  8. 2006-11-01

    Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder--a pilot study

    ✓ Peer-reviewed Getting a diagnosis The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: These results suggest that the SLUMS and MMSE have comparable sensitivities, specificities, and area under the curve in detecting dementia. +2 more findings

  9. 2006-11-01

    The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening

    ✓ Peer-reviewed Getting a diagnosis International journal of geriatric psychiatry

    Key finding: Reliability of the ACE-R was very good (alpha coefficient=0.8). +1 more finding

  10. 2006-11-01

    Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study

    ✓ Peer-reviewed Prevention and risk Archives of neurology

    Key finding: Ninety-nine new cases of dementia (including 71 of Alzheimer disease) occurred during the follow-up. +3 more findings

  11. 2006-11-01

    Design of Depression in Alzheimer's Disease Study-2

    ✓ Peer-reviewed Treatments The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: The authors believe these design elements are important features to be included in trials of depression and other neuropsychiatric disturbances in Alzheimer disease. +3 more findings

  12. 2006-11-01
  13. 2006-11-01

    Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Greater access to effective programs of counseling and support could yield considerable benefits for caregivers, patients with Alzheimer disease, and society. +1 more finding

  14. 2006-11-01

    Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial

    ✓ Peer-reviewed Treatments Annals of internal medicine

    Key finding: A structured multicomponent intervention adapted to individual risk profiles can increase the quality of life of ethnically diverse dementia caregivers.

October 2006 11

  1. 2006-10-30

    TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

    ✓ Peer-reviewed Lewy body dementia Biochemical and biophysical research communications

    Key finding: Dephosphorylation treatment of the sarkosyl insoluble fraction has shown that abnormal phosphorylation takes place in accumulated TDP-43. +1 more finding

  2. 2006-10-29

    Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides

    ✓ Peer-reviewed Brain scans and imaging Nature nanotechnology

    Key finding: These data indicate that the nanoceria particles may be effective in inhibiting the progression of ROI-induced cell death, which is thought to be involved in macular degeneration, retinitis pigmentosa and other blinding diseases, as well as the ROI-induced death of other cell types in diabetes, Alzheimer's disease, atherosclerosis, stroke and so on. +1 more finding

  3. 2006-10-27

    Alzheimer disease, the two-hit hypothesis: an update

    ✓ Peer-reviewed Drug development Biochimica et biophysica acta

    Key finding: Given the relative modality of single-insult models to accurately reflect Alzheimer disease pathogenesis, based on studies on mitogenic and oxidative stress signaling pathways, we proposed a two-hit hypothesis 2 years ago stating that both oxidative stress and mitogenic dysregulation are necessary and sufficient to cause the disease and suggested that it may be a common mechanism for other neurodegenerative diseases as well (X.

  4. 2006-10-24

    Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert

    ✓ Peer-reviewed Disease mechanisms Journal of neurochemistry

    Key finding: We used this transgenic model to address two issues: first, whether chronic lithium treatment is able to prevent the formation of aberrant tau aggregates that result from the overexpression of FTDP-17 tau and GSK-3beta; second, whether lithium is able to change back already formed NFTs in aged animals. +2 more findings

  5. 2006-10-24

    Mutations of presenilin genes in dilated cardiomyopathy and heart failure

    ✓ Peer-reviewed Risk genes beyond APOE American journal of human genetics

    Key finding: Heart failure usually results from dilated cardiomyopathy (DCM). +3 more findings

  6. 2006-10-24

    A multidisciplinary, multifactorial intervention program reduces postoperative falls and injuries after femoral neck fracture

    ✓ Peer-reviewed Prevention and risk Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

    Key finding: A team applying comprehensive geriatric assessment and rehabilitation, including prevention, detection, and treatment of fall risk factors, can successfully prevent inpatient falls and injuries, even in patients with dementia. +1 more finding

  7. 2006-10-20

    Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience and biobehavioral reviews

    Key finding: More recently, emerging evidence indicates that intraneuronal accumulation of Abeta may also contribute to the cascade of neurodegenerative events and strongly suggest that it is an early, pathological biomarker for the onset of AD and associated cognitive and other behavioral deficits.

  8. 2006-10-20

    Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles

    ✓ Peer-reviewed Disease mechanisms The Journal of biological chemistry

    Key finding: Our results show that Abeta immunotherapy reduces soluble tau and ameliorates behavioral deficit in old transgenic mice.

  9. 2006-10-18

    Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats

    ✓ Peer-reviewed Disease mechanisms Biochimica et biophysica acta

    Key finding: As a potential underlying mechanism, we were able to determine that transient ischemia induced tau hyperphosphorylation and NFT-like conformations are associated with aberrant activation of cyclin dependent kinase 5 (Cdk5) and can be rescued by delivery of a potent, but non-specific cyclin dependent kinase inhibitor, roscovitine to the brain. +2 more findings

  10. 2006-10-18

    Inflammatory changes parallel the early stages of Alzheimer disease

    ✓ Peer-reviewed Inflammation and the immune system Neurobiology of aging

    Key finding: To determine changes in the AD brain that may mediate the transition into dementia, the gene expression of approximately 10,000 full-length genes was compared in mild/moderate dementia cases to non-demented controls that exhibited high AD pathology. +3 more findings

  11. 2006-10-16

    Subjective memory complaints and cognitive impairment in older people

    ✓ Peer-reviewed Getting a diagnosis Dementia and geriatric cognitive disorders

    Key finding: In conclusion, the determinants of SMCs are complex.

Browse the library by subject, with the full score breakdown →